Omega Healthcare Investors (OHI) FY2012 results: revenue $350 million, up 19.9% on the year
Omega Healthcare Investors Inc. (OHI) reported revenue of $350 million for fiscal 2012, the year ended 31 December 2012, up 19.9% on the year before. Net income was $121 million, up 129.4%, and diluted earnings per share $1.12. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2013.
Revenue
$350 million
+19.9% on the year
FY2008FY2012
Operating margin
61.3%
47.2% a year earlier
FY2008FY2012
Net income
$121 million
+129.4% on the year
FY2008FY2012
Diluted EPS
$1.12
+143.5% on the year
FY2008FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
350
292
258
+19.9%
Operating income
215
138
149
+56.0%
Operating margin
61.3%
47.2%
57.7%
Interest expense
95.5
81.2
67.3
+17.7%
Pre-tax income
n/a
n/a
58.4
Income tax
n/a
n/a
0.0
Effective tax rate
n/a
n/a
0.0%
Net income
121
52.6
58.4
+129.4%
Net margin
34.4%
18.0%
22.6%
Diluted EPS
$1.12
$0.46
$0.52
+143.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
208
170
158
+22.7%
Capital expenditure
29.4
19.6
36.0
+50.2%
Free cash flow
179
150
122
+19.1%
Free cash flow margin
51.0%
51.4%
47.0%
Cash from investing
-391
-258
-395
Cash from financing
184
81.3
242
+126.1%
Depreciation and amortisation
113
100
84.6
+12.6%
Share-based compensation
5.9
6.0
2.2
-1.6%
Buybacks
n/a
2.9
n/a
Dividends paid
182
162
139
+12.5%
Dividend per share
$1.69
$1.55
$1.37
+9.0%
Diluted shares, weighted
108m
102m
94m
+5.7%
Shares outstanding at period end
112m
103m
99m
+8.7%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
1,011
878
1,004
+15.1%
Debt
1,825
1,551
1,177
+17.6%
Other liabilities
146
127
123
+14.4%
Total liabilities and equity
2,982
2,557
2,304
+16.6%
Cash and equivalents
1.7
0.4
6.9
+387.5%
Other assets
2,980
2,557
2,297
+16.6%
Total assets
2,982
2,557
2,304
+16.6%
10-K for the year ended 31 December 2012, filed 28 February 2013: the filing.